Drug · DIN 00525103
S2
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 20, 2018; first marketed October 2, 1998.
- Drug Identification Number (DIN)
- 00525103
- Company (DIN owner)
- Nephron Pharmaceuticals CorporationWest Columbia, South Carolina, United States
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Inhalation
- Therapeutic class (ATC)
- Epinephrine R03AA01
- Class
- Human
- Record last updated
- June 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EPINEPHRINE RACEMIC | 2.25 % |